Status:
ACTIVE_NOT_RECRUITING
STEPuP: Prenatal Provider Education and Training to Improve Medication-assisted Treatment Use During Pregnancy
Lead Sponsor:
University of Pittsburgh
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Opioid-use Disorder
Pregnancy Related
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This research will test the effectiveness of a prenatal provider education and training program designed to facilitate provider adoption of evidence-based practices for the treatment of OUD during pre...
Detailed Description
The prevalence of opioid use disorder (OUD) during pregnancy has quadrupled over the past decade, as have maternal and neonatal morbidity and mortality related to substance use. Medication assisted tr...
Eligibility Criteria
Inclusion
- Providers:
- provides prenatal care (i.e. obstetricians, nurse midwives, advanced practice providers) at obstetric sites,
- provides care to pregnant women with OUD
- English speaking
- Patient:
- Maternal and child outcome data will be collected from the Electronic Health Record (EHR) and individual patients will not be recruited to participate in the randomized controlled trial (RCT).
- Inclusion criteria for a small subset of pregnant women will be recruited for a one-time qualitative interview (n=50):
- meet The Diagnostic and Statistical Manual of Mental Disorders (DSM-V) criteria for OUD
- received care at participating sites while pregnant during the study time period and
- speak English
Exclusion
- None
Key Trial Info
Start Date :
September 30 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 30 2026
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04527926
Start Date
September 30 2020
End Date
April 30 2026
Last Update
October 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Magee Womens Hospital of UPMC
Pittsburgh, Pennsylvania, United States, 15213